HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- hydroxy- 7,4'- diacetyloxyflavanone- N- phenyl hydrazone

structure in first source

Also Known As:

N101-43 cpd

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - Hydrazones: 500
    - 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavanones: 184
        5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavanones: 184
        5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone: 1

Experts

1.	Bak, Yesol: 1 article (09/2011)
2.	Hong, Jintae: 1 article (09/2011)
3.	Jung, Kang-Yeoun: 1 article (09/2011)
4.	Kang, Jeong-Woo: 1 article (09/2011)
5.	Kim, Heejong: 1 article (09/2011)
6.	Kim, Jung-Hee: 1 article (09/2011)
7.	Kim, Man Sub: 1 article (09/2011)
8.	Lee, Dong Hun: 1 article (09/2011)
9.	Lim, Yoongho: 1 article (09/2011)
10.	Park, Yun Sun: 1 article (09/2011)

Related Diseases

1.	Neoplasms (Cancer) 09/28/2011 - "In this study, naringenin was derivatized to produce more effective small-molecule inhibitors of cancer cell proliferation, and the anticancer effects of its derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), in non-small-cell lung cancer (NSCLC) cell lines NCI-H460, A549, and NCI-H1299 were investigated. "
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/28/2011 - "A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells." 09/28/2011 - "In this study, naringenin was derivatized to produce more effective small-molecule inhibitors of cancer cell proliferation, and the anticancer effects of its derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), in non-small-cell lung cancer (NSCLC) cell lines NCI-H460, A549, and NCI-H1299 were investigated. "

Related Drugs and Biologics

1.	naringenin